Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:PRG NYSE:RSI NASDAQ:UPST NASDAQ:VVOS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePRGPROG$44.29+0.2%$38.13$25.80▼$47.60$1.77B1.78638,329 shs372,687 shsRSIRush Street Interactive$33.38+2.3%$28.67$14.38▼$33.52$7.77B1.563.17 million shs1.36 million shsUPSTUpstart$32.74-1.5%$31.33$23.97▼$87.30$3.13B2.264.11 million shs2.69 million shsVVOSVivos Therapeutics$0.43-7.2%$0.60$0.38▼$7.95$6M6.16958,266 shs172,314 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePRGPROG0.00%+0.54%+19.11%+50.79%+46.56%RSIRush Street Interactive0.00%+5.50%+13.73%+57.67%+115.10%UPSTUpstart0.00%-5.87%+2.99%+20.10%-58.25%VVOSVivos Therapeutics0.00%-4.68%-29.61%-64.30%-92.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePRGPROG$44.29+0.2%$38.13$25.80▼$47.60$1.77B1.78638,329 shs372,687 shsRSIRush Street Interactive$33.38+2.3%$28.67$14.38▼$33.52$7.77B1.563.17 million shs1.36 million shsUPSTUpstart$32.74-1.5%$31.33$23.97▼$87.30$3.13B2.264.11 million shs2.69 million shsVVOSVivos Therapeutics$0.43-7.2%$0.60$0.38▼$7.95$6M6.16958,266 shs172,314 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePRGPROG0.00%+0.54%+19.11%+50.79%+46.56%RSIRush Street Interactive0.00%+5.50%+13.73%+57.67%+115.10%UPSTUpstart0.00%-5.87%+2.99%+20.10%-58.25%VVOSVivos Therapeutics0.00%-4.68%-29.61%-64.30%-92.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePRGPROG 2.56Moderate Buy$47.366.93% UpsideRSIRush Street Interactive 2.85Moderate Buy$29.63-11.26% DownsideUPSTUpstart 2.24Hold$45.2038.06% UpsideVVOSVivos Therapeutics 2.25Hold$2.80548.15% UpsideCurrent Analyst Ratings BreakdownLatest UPST, PRG, RSI, and VVOS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2026UPSTUpstart The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$32.00 ➝ $39.007/8/2026RSIRush Street Interactive CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform7/8/2026PRGPROG Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$33.00 ➝ $60.007/8/2026PRGPROG Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$33.00 ➝ $60.007/8/2026RSIRush Street Interactive Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$30.00 ➝ $33.007/7/2026PRGPROG TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$45.00 ➝ $50.007/7/2026UPSTUpstart BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$43.007/7/2026UPSTUpstart Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$37.00 ➝ $40.007/6/2026RSIRush Street Interactive Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)7/1/2026PRGPROG Loop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$48.006/29/2026PRGPROG Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 7/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPRGPROG$2.41B0.74$44.29 per share1.00$18.86 per share2.35RSIRush Street Interactive$1.13B6.85$0.44 per share76.17$1.32 per share25.29UPSTUpstart$1.04B3.00$0.81 per share40.61$8.21 per share3.99VVOSVivos Therapeutics$17.44M0.34N/AN/A($0.16) per share-2.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePRGPROG$146.79M$3.6612.108.36N/A5.88%21.94%9.54%7/29/2026 (Estimated)RSIRush Street Interactive$33.31M$0.31107.6953.84N/A2.98%17.21%8.00%7/29/2026 (Estimated)UPSTUpstart$53.60M$0.3886.1619.260.864.34%5.63%1.49%8/4/2026 (Estimated)VVOSVivos Therapeutics-$21.17M-$2.14N/AN/AN/A-127.70%-2,325.64%-98.12%8/18/2026 (Estimated)Latest UPST, PRG, RSI, and VVOS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026UPSTUpstart$0.55N/AN/AN/A$348.73 millionN/A7/29/2026Q2 2026PRGPROG$0.96N/AN/AN/A$713.50 millionN/A7/29/2026Q2 2026RSIRush Street Interactive$0.13N/AN/AN/A$362.85 millionN/A5/20/2026Q1 2026VVOSVivos Therapeutics-$0.45-$0.52-$0.07-$0.52$4.35 million$5.14 million5/5/2026Q1 2026UPSTUpstart$0.39-$0.07-$0.46-$0.07$301.30 million$308.21 million4/29/2026Q1 2026PRGPROG$0.78$1.24+$0.46$0.89$732.70 million$742.67 million4/28/2026Q1 2026RSIRush Street Interactive$0.12$0.14+$0.02$0.08$330.83 million$370.36 million4/15/2026Q4 2025VVOSVivos Therapeutics-$0.4950-$0.58-$0.0850-$0.58$7.10 million$3.82 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthPRGPROG$0.561.26%-44.37%15.30%2 YearsRSIRush Street InteractiveN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/AVVOSVivos TherapeuticsN/AN/AN/AN/AN/ALatest UPST, PRG, RSI, and VVOS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2026PRGPROGquarterly$0.141.7%5/19/20265/19/20266/2/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPRGPROG1.214.272.41RSIRush Street InteractiveN/A1.961.96UPSTUpstartN/A0.490.49VVOSVivos TherapeuticsN/A0.270.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPRGPROG97.92%RSIRush Street Interactive24.78%UPSTUpstart63.01%VVOSVivos Therapeutics26.35%Insider OwnershipCompanyInsider OwnershipPRGPROG3.72%RSIRush Street Interactive52.89%UPSTUpstart17.29%VVOSVivos Therapeutics2.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePRGPROG1,15140.07 million38.58 millionNot OptionableRSIRush Street Interactive470232.70 million109.62 millionNot OptionableUPSTUpstart1,40595.71 million79.16 millionOptionableVVOSVivos Therapeutics16013.90 million13.60 millionOptionableUPST, PRG, RSI, and VVOS HeadlinesRecent News About These CompaniesVivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth AssumptionsJuly 3, 2026 | finance.yahoo.comVivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study ParticipantsJune 30, 2026 | markets.businessinsider.comVivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study ParticipantsJune 30, 2026 | globenewswire.comVivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred EquityJune 22, 2026 | globenewswire.comVivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights OfferingJune 11, 2026 | globenewswire.comVivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to ...June 10, 2026 | markets.businessinsider.comVivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular PatientsJune 10, 2026 | globenewswire.comVivos Therapeutics, Inc. to Present at The Small Cap Showcase & WTR Insights on June 9, 2026June 8, 2026 | quiverquant.comQVivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026June 8, 2026 | globenewswire.comVivos Therapeutics Announces Debt Exchange Agreement with Streeterville Capital to Strengthen Financial PositionJune 5, 2026 | quiverquant.comQVivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq ListingJune 5, 2026 | globenewswire.comVivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic ShiftsMay 29, 2026 | finance.yahoo.comVivos Therapeutics Balances Rapid Growth With Cash StrainMay 22, 2026 | tipranks.comVivos Therapeutics Earnings Call: Growth Meets Cash StrainMay 21, 2026 | tipranks.comVivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational UpdateMay 21, 2026 | finanznachrichten.deVivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call TranscriptMay 21, 2026 | seekingalpha.comVivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational UpdateMay 20, 2026 | globenewswire.comVivos Therapeutics Delays Quarterly FilingMay 15, 2026 | tipranks.comAnalysts see 200%+ upside in these 3 high-risk stocks: here's why?May 9, 2026 | invezz.comIVivos Therapeutics (VVOS) price target decreased by 51.67% to 2.47April 29, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesOracle’s Sell-Off Looks More Like a Mispricing Than a WarningBy Thomas Hughes | June 23, 20263 ETFs Giving Ready-Made Access to the Discounted International Small-Cap SpaceBy Nathan Reiff | June 14, 2026Time to Sell? 3 Winners With Fading Technical MomentumBy Dan Schmidt | June 13, 2026Apple’s Intel Deal Arrives at the Right Time for Its StockBy Sam Quirke | June 23, 20263 Space ETFs for a Timely InvestmentBy Nathan Reiff | June 18, 2026UPST, PRG, RSI, and VVOS Company DescriptionsPROG NYSE:PRG$44.29 +0.10 (+0.22%) Closing price 07/10/2026 03:59 PM EasternExtended Trading$44.24 -0.04 (-0.10%) As of 07/10/2026 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PROG Holdings, Inc. (NYSE:PRG) is a financial technology holding company based in Salt Lake City, Utah with three business segments: Progressive Leasing, which offers lease-to-own transactions primarily to credit-challenged consumers through e-commerce and point-of-sale retail partners, via online, mobile, and in-store solutions; Vive Financial, which provides consumers who may not qualify for traditional prime lending with a variety of second-look, revolving credit products through private label and branded credit cards; and Four Technologies, which provides consumers of all credit backgrounds Buy Now, Pay Later (BNPL) options through four interest-free installments via its platform, Four.Rush Street Interactive NYSE:RSI$33.38 +0.75 (+2.31%) Closing price 07/10/2026 03:59 PM EasternExtended Trading$33.28 -0.10 (-0.31%) As of 07/10/2026 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Rush Street Interactive, Inc. operates as an online casino and sports betting company in the United States, Canada, Mexico, and rest of Latin America. It provides real-money online casino, online and retail sports betting, and social gaming services. In addition, the company offers full suite of games comprising of bricks-and-mortar casinos, table games, and slot machines. The company markets its online casino and sports betting under BetRivers, PlaySugarHouse, and RushBet brands. Rush Street Interactive, Inc. was founded in 2012 and is headquartered in Chicago, Illinois.Upstart NASDAQ:UPST$32.74 -0.49 (-1.47%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$32.79 +0.05 (+0.14%) As of 07/10/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California.Vivos Therapeutics NASDAQ:VVOS$0.43 -0.03 (-7.22%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.43 0.00 (0.00%) As of 07/10/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/06 - 07/10 Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing Why WD-40 Is Proving Great Businesses Never Go Out of Style Rocket Lab’s Stock Drop Comes With a Bullish Twist Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs Power Struggle: Wolfspeed Sues Navitas Over AI Chips Pushing the Edge: Super Micro Computer Reboots the AI Landscape Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
